Search

Your search keyword '"Perez-Mancera, Pedro A."' showing total 27 results

Search Constraints

Start Over You searched for: Author "Perez-Mancera, Pedro A." Remove constraint Author: "Perez-Mancera, Pedro A." Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
27 results on '"Perez-Mancera, Pedro A."'

Search Results

1. Figure S7 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

2. Supplementary Table S12 from Tissue-Specific Oncogenic Activity of KRASA146T

3. Supplementary Tables S14-S17 from Tissue-Specific Oncogenic Activity of KRASA146T

4. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

5. Data from Tissue-Specific Oncogenic Activity of KRASA146T

6. Supplementary Figures S1-S18 from Tissue-Specific Oncogenic Activity of KRASA146T

7. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

8. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

9. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

10. Data from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

11. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

12. Supplementary Figure Legends, Supplementary Tables 1 and 2 and Supplementary Materials and Methods from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

13. Supplementary Figures 1 through 9 from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

14. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

15. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

16. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

17. Supplementary Figure 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

18. Abstract C084: Oncogenic KRAS signaling drives the activation of tissue-resident fibroblasts and is required to maintain CAF heterogeneity in pancreatic cancer

19. Abstract 3647: Oncogenic Kras drives cancer-associated fibroblast heterogeneity and substate changes in pancreatic cancer

20. Tissue-Specific Oncogenic Activity of KRASA146T

21. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

23. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

24. Tissue-Specific Oncogenic Activity of KRASA146T

25. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

26. Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes.

Catalog

Books, media, physical & digital resources